LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
LeMaitre Vascular (NASDAQ:LMAT): A Quality Stock for Long-Term Investors
LeMaitre Vascular: The Q2 Miss Hides A Stronger Acquisition Machine
Is LeMaitre Vascular (LMAT) A Bargain Following Its 90 Day Pullback?
LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run
Speculative Rally Weighed on LeMaitre Vascular (LMAT)
LeMaitre to Participate at Upcoming Investor Conferences in September
Q2 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
The Top 5 Analyst Questions From LeMaitre’s Q2 Earnings Call
LeMaitre Vascular: 31% Drawdown On $0.02 Guidance Cut
LeMaitre Vascular (LMAT) Q2 2026 Earnings Call Transcript
31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update
LeMaitre Vascular (LMAT) Hit by Profit Taking
LeMaitre Vascular, Inc. Q2 2026 Earnings Call Summary
Wells Fargo Maintains Equal-Weight on LeMaitre Vascular, Lowers Price Target to $94
LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ...
LeMaitre Vascular (NASDAQ:LMAT) Shares Slide on Q2 Earnings Miss
LeMaitre Vascular Q2 Earnings Call Highlights
LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates
LeMaitre Vascular, Inc. (LMAT) Q2 2026 Earnings Call Transcript
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.